See-sawing global tariffs, a US regulator in flux and a possible end to US drug price premia are not, apparently, enough to ...

New York-based Formation Bio, an AI-native pharma company focused on accelerating drug development, revealed that its ...

The US Food and Drug Administration (FDA) has approved Datroway (datopotamab deruxtecan or Dato-DXd) to treat adults with ...

Swiss pharma giant Roche has announced positive Phase I/II data on NXT007 in people with hemophilia A, supporting its ...

The revision of the European pharmaceutical legislation, the reform of the Supplementary Protection Certificate (SPC) system ...

Danish diabetes and obesity giant Novo Nordisk yesterday announced that it will no longer be working with Hims & Hers Health ...

The UK-based firm earlier announced that it had met the primary endpoint in the ongoing 258-patient Phase III COMP005 trial, ...

AI precision-medicine company Sonrai Analytics and German biotech Plectonic Biotech have entered a partnership to accelerate ...

Obesity late-comer Amgen announced full results from Part 1 of the Phase II study of MariTide (maridebart cafraglutide, ...

Cidara Therapeutics, a US biotech leveraging its Cloudbreak platform for next‑generation antivirals, saw its stock more than ...

New Jersey, USA-based clinical-stage biotech OnCusp Therapeutics has announced the appointment of Dr Dimitry Nuyten as chief ...

Licensing of innovator oligonucleotide drugs for central nervous system (CNS) indications surged 339% in 2024, jumping from ...